Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral Tracking
1.2.3 Vein Tracking
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Solutions Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Health Systems
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Solutions Market Perspective (2018-2029)
2.2 Radiopharmaceutical Solutions Growth Trends by Region
2.2.1 Global Radiopharmaceutical Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radiopharmaceutical Solutions Historic Market Size by Region (2018-2023)
2.2.3 Radiopharmaceutical Solutions Forecasted Market Size by Region (2024-2029)
2.3 Radiopharmaceutical Solutions Market Dynamics
2.3.1 Radiopharmaceutical Solutions Industry Trends
2.3.2 Radiopharmaceutical Solutions Market Drivers
2.3.3 Radiopharmaceutical Solutions Market Challenges
2.3.4 Radiopharmaceutical Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Solutions Players by Revenue
3.1.1 Global Top Radiopharmaceutical Solutions Players by Revenue (2018-2023)
3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceutical Solutions Revenue
3.4 Global Radiopharmaceutical Solutions Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Solutions Revenue in 2022
3.5 Radiopharmaceutical Solutions Key Players Head office and Area Served
3.6 Key Players Radiopharmaceutical Solutions Product Solution and Service
3.7 Date of Enter into Radiopharmaceutical Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Solutions Breakdown Data by Type
4.1 Global Radiopharmaceutical Solutions Historic Market Size by Type (2018-2023)
4.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2024-2029)
5 Radiopharmaceutical Solutions Breakdown Data by Application
5.1 Global Radiopharmaceutical Solutions Historic Market Size by Application (2018-2023)
5.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Radiopharmaceutical Solutions Market Size (2018-2029)
6.2 North America Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Radiopharmaceutical Solutions Market Size by Country (2018-2023)
6.4 North America Radiopharmaceutical Solutions Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopharmaceutical Solutions Market Size (2018-2029)
7.2 Europe Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Radiopharmaceutical Solutions Market Size by Country (2018-2023)
7.4 Europe Radiopharmaceutical Solutions Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Solutions Market Size (2018-2029)
8.2 Asia-Pacific Radiopharmaceutical Solutions Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiopharmaceutical Solutions Market Size (2018-2029)
9.2 Latin America Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Radiopharmaceutical Solutions Market Size by Country (2018-2023)
9.4 Latin America Radiopharmaceutical Solutions Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Solutions Market Size (2018-2029)
10.2 Middle East & Africa Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBA
11.1.1 IBA Company Detail
11.1.2 IBA Business Overview
11.1.3 IBA Radiopharmaceutical Solutions Introduction
11.1.4 IBA Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.1.5 IBA Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Radiopharmaceutical Solutions Introduction
11.2.4 GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.2.5 GE Healthcare Recent Development
11.3 Actinium Pharmaceuticals
11.3.1 Actinium Pharmaceuticals Company Detail
11.3.2 Actinium Pharmaceuticals Business Overview
11.3.3 Actinium Pharmaceuticals Radiopharmaceutical Solutions Introduction
11.3.4 Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.3.5 Actinium Pharmaceuticals Recent Development
11.4 Alseres Pharmaceuticals
11.4.1 Alseres Pharmaceuticals Company Detail
11.4.2 Alseres Pharmaceuticals Business Overview
11.4.3 Alseres Pharmaceuticals Radiopharmaceutical Solutions Introduction
11.4.4 Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.4.5 Alseres Pharmaceuticals Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Detail
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Radiopharmaceutical Solutions Introduction
11.5.4 Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.5.5 Cardinal Health Recent Development
11.6 Jubilant Pharma
11.6.1 Jubilant Pharma Company Detail
11.6.2 Jubilant Pharma Business Overview
11.6.3 Jubilant Pharma Radiopharmaceutical Solutions Introduction
11.6.4 Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.6.5 Jubilant Pharma Recent Development
11.7 Central Research Laboratories
11.7.1 Central Research Laboratories Company Detail
11.7.2 Central Research Laboratories Business Overview
11.7.3 Central Research Laboratories Radiopharmaceutical Solutions Introduction
11.7.4 Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.7.5 Central Research Laboratories Recent Development
11.8 Cyclomedica
11.8.1 Cyclomedica Company Detail
11.8.2 Cyclomedica Business Overview
11.8.3 Cyclomedica Radiopharmaceutical Solutions Introduction
11.8.4 Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.8.5 Cyclomedica Recent Development
11.9 Bracco
11.9.1 Bracco Company Detail
11.9.2 Bracco Business Overview
11.9.3 Bracco Radiopharmaceutical Solutions Introduction
11.9.4 Bracco Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.9.5 Bracco Recent Development
11.10 Eckert & Ziegler Radiopharma
11.10.1 Eckert & Ziegler Radiopharma Company Detail
11.10.2 Eckert & Ziegler Radiopharma Business Overview
11.10.3 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Introduction
11.10.4 Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.10.5 Eckert & Ziegler Radiopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details